secwatch.observer — SEC 8-K summary
======================================

Issuer:     Abpro Holdings, Inc. (ABPO)
CIK:        0001893219
Form:       8-K
Filed at:   2024-12-12T23:59:59+00:00
Accession:  0001213900-24-108370
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Abpro celebrates business combination close; raises $10M and secures $50M equity facility
--------------------------------------------------------------------------------

- Business combination with ACAB closed Nov 13, 2024; Nasdaq bell ringing ceremony held Dec 12.
- Raised $10M gross proceeds ($7M PIPE + $2.76M convertible note) and secured up to $50M equity facility from Yorkville.
- Funds to support development of antibody pipeline for HER2+ cancers, wet AMD, DME, and infectious diseases.
- Partnered with Celltrion to advance ABP 102 T-cell engager for HER2+ breast, gastric, pancreatic cancers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1893219/000121390024108370/0001213900-24-108370-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1893219/000121390024108370/ea022449301-8k_abpro.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-108370

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer